Completed PHASE1 INTERVENTIONAL 1-arm NCT04250792

Efficacy of Low Dose Naltrexone in Psoriasis

Efficacy of Low Dose Naltrexone in Psoriasis; Clinical Trial in a Tertiary Care Hospital of Karachi.

Sponsor: Jinnah Postgraduate Medical Centre

Conditions Psoriasis

Updated 4 times since 2020 Last updated: Jan 29, 2020 Started: Jan 1, 2019 Primary completion: Jul 31, 2019 Completion: Sep 30, 2019

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT04250792, this PHASE1 trial focuses on Psoriasis and remains completed. Sponsored by Jinnah Postgraduate Medical Centre, it has been updated 4 times since 2019, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

Change History

4 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE1
Jul 2024 — Sep 2024 [monthly]

Completed PHASE1
Jan 2021 — Jul 2024 [monthly]

Completed PHASE1
Feb 2020 — Jan 2021 [monthly]

Completed PHASE1

First recorded

Jan 2019

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Jinnah Postgraduate Medical Centre

Data source: Jinnah Postgraduate Medical Centre

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Karachi, Pakistan